Fasenra pen 30 MG/mlml
Ended Awarded
- Contract number
- SPE2DR26FQP2Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,645
Award facts
- Contract value 100% obligated
- $39,645.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $39,645.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FASENRA Pen 30 mg/mL pharmaceutical supplies. The award, issued on November 4, 2025, with an ultimate completion date of November 26, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. FASENRA (benralizumab) is a specialty biologic medication used in the treatment of severe eosinophilic asthma, reflecting the Defense Health Agency's need for critical specialty pharmaceuticals to support military and veteran healthcare requirements.
This delivery order is a child contract under AmerisourceBergen's $999,999,999 comprehensive pharmaceutical IDC with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and serves as the primary global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen is one of the largest pharmaceutical distributors supporting federal medical procurement, and this award demonstrates its ongoing role as a critical vendor for specialty drug delivery across the defense healthcare system. No small business set-aside was utilized for this procurement, consistent with the company's typical competitive award pattern for open federal pharmaceutical contracts.
Quick answers
Who was awarded contract SPE2DR26FQP2Z?
SPE2DR26FQP2Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FQP2Z worth?
The government has obligated $39,645 on SPE2DR26FQP2Z.
Is contract SPE2DR26FQP2Z an order under another contract?
Yes. SPE2DR26FQP2Z is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQP2Z competed?
The extent of competition for SPE2DR26FQP2Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award